Amanda Owens Appointed at Precision for Medicine to Enhance Biospecimen Access for Research

Amanda Owens Appointed at Precision for Medicine

Precision for Medicine recently announced the appointment of Amanda Owens as General Manager of Biospecimen Solutions. With a wealth of experience in life sciences, Owens is set to drive the commercial and operational strategies that will enhance access to fit-for-purpose biospecimens essential for advanced research and the development of next-generation therapies.

Enhancing Research Capabilities

In the evolving landscape of biopharmaceutical research, the demand for deeply annotated biospecimens is on the rise. Owens' role at Precision comes at a crucial time when high-quality biospecimens rich in genetic and molecular data are indispensable for innovative drug development. Owens aims to lead initiatives that provide enhanced access to these specimens, directly supporting the intricate needs of biopharma companies engaged in cutting-edge research.

"Access to fully characterized biological samples has become a strategic imperative," remarked Sofia Baig, President of Precision for Medicine. “Owens's extensive background will help us ensure the market leverages our deep biorepository resources effectively. With over one million biofluid and three million tissue specimens available, Precision's commitment to quality combined with Amanda's leadership will accelerate drug discovery processes for our clients."

A Proven Leader in Life Sciences

Owens brings significant expertise from her previous leadership roles in the biospecimen sector. She has a proven track record at Landmark Bio and Discovery Life Sciences, where she successfully built commercial operations and expanded strategic partnerships essential for business growth. Her extensive background encompasses various areas of life sciences, including genomics and gene editing, all crucial for providing the biopharma industry with the top-tier biospecimens required today.

Owens emphasizes that matching the right biospecimen to the correct research project requires a deep understanding of both current and evolving scientific needs. "It is vital to grasp what sponsors require at present while anticipating their future research needs," she stated. "Quality is paramount, and Precision's laboratory capabilities allow us to go beyond merely supplying a biospecimen to a more comprehensive approach that includes detailed biological characterization. This synergy not only enables a more consultative partnership but also addresses the central challenges of our industry."

Educational Background

Owens, who is based in Nashville, TN, holds an MBA from the University of Alabama in Huntsville. Additionally, she earned her master's degree in Biological Anthropology and a bachelor's degree in Biology from the University of Alabama. This multidisciplinary academic foundation has shaped her strategy development that aligns scientific requirements with commercial goals, reinforcing her role at Precision for Medicine.

About Precision for Medicine

Precision for Medicine is a premier biomarker-driven organization that provides clinical research and development services tailored to meet the demands of life sciences companies. Their integrated approach combines clinical trial design with extensive scientific knowledge and advanced data capabilities, fostering faster clinical development and market approval. With over 3,500 professionals across more than 50 locations worldwide, Precision for Medicine is committed to enhancing research effectiveness through innovative biospecimen solutions. For more information, visit PrecisionForMedicine.com.